These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


288 related items for PubMed ID: 22245501

  • 1. Corticotropin-releasing factor in the nucleus accumbens shell induces swim depression, anxiety, and anhedonia along with changes in local dopamine/acetylcholine balance.
    Chen YW, Rada PV, Bützler BP, Leibowitz SF, Hoebel BG.
    Neuroscience; 2012 Mar 29; 206():155-66. PubMed ID: 22245501
    [Abstract] [Full Text] [Related]

  • 2. Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior.
    Slawecki CJ, Thorsell AK, El Khoury A, Mathé AA, Ehlers CL.
    Neuropeptides; 2005 Aug 29; 39(4):369-77. PubMed ID: 16038974
    [Abstract] [Full Text] [Related]

  • 3. Site-specific genetic manipulation of amygdala corticotropin-releasing factor reveals its imperative role in mediating behavioral response to challenge.
    Regev L, Tsoory M, Gil S, Chen A.
    Biol Psychiatry; 2012 Feb 15; 71(4):317-26. PubMed ID: 21783178
    [Abstract] [Full Text] [Related]

  • 4. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY, van Leeuwen ML, Westphal KG, Olivier B, Groenink L.
    Neuroscience; 2011 Jan 26; 173():82-92. PubMed ID: 21093544
    [Abstract] [Full Text] [Related]

  • 5. Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice.
    Umathe SN, Bhutada PS, Jain NS, Shukla NR, Mundhada YR, Dixit PV.
    Neuropeptides; 2008 Aug 26; 42(4):399-410. PubMed ID: 18533256
    [Abstract] [Full Text] [Related]

  • 6. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes.
    Lu L, Liu Z, Huang M, Zhang Z.
    J Neurochem; 2003 Mar 26; 84(6):1378-86. PubMed ID: 12614338
    [Abstract] [Full Text] [Related]

  • 7. Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice.
    Bhutada P, Mundhada Y, Bansod K, Ubgade A, Quazi M, Umathe S, Mundhada D.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug 16; 34(6):955-60. PubMed ID: 20447436
    [Abstract] [Full Text] [Related]

  • 8. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E, Sanna PP, Koob GF.
    Pharmacol Biochem Behav; 2005 Aug 16; 81(4):701-8. PubMed ID: 16005056
    [Abstract] [Full Text] [Related]

  • 9. Behavioral depression in the swim test causes a biphasic, long-lasting change in accumbens acetylcholine release, with partial compensation by acetylcholinesterase and muscarinic-1 receptors.
    Rada P, Colasante C, Skirzewski M, Hernandez L, Hoebel B.
    Neuroscience; 2006 Aug 11; 141(1):67-76. PubMed ID: 16677771
    [Abstract] [Full Text] [Related]

  • 10. The role of glucocorticoids in the uncontrollable stress-induced potentiation of nucleus accumbens shell dopamine and conditioned place preference responses to morphine.
    Der-Avakian A, Bland ST, Schmid MJ, Watkins LR, Spencer RL, Maier SF.
    Psychoneuroendocrinology; 2006 Jun 11; 31(5):653-63. PubMed ID: 16584846
    [Abstract] [Full Text] [Related]

  • 11. Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell.
    Rada P, Avena NM, Hoebel BG.
    Neuroscience; 2005 Jun 11; 134(3):737-44. PubMed ID: 15987666
    [Abstract] [Full Text] [Related]

  • 12. Behavioral effects and CRF expression in brain structures of high- and low-anxiety rats after chronic restraint stress.
    Wisłowska-Stanek A, Lehner M, Skórzewska A, Krząścik P, Płaźnik A.
    Behav Brain Res; 2016 Sep 01; 310():26-35. PubMed ID: 27150225
    [Abstract] [Full Text] [Related]

  • 13. Activation of CRF/CRFR1 signaling in the basolateral nucleus of the amygdala contributes to chronic forced swim-induced depressive-like behaviors in rats.
    Chen L, Li S, Cai J, Wei TJ, Liu LY, Zhao HY, Liu BH, Jing HB, Jin ZR, Liu M, Wan Y, Xing GG.
    Behav Brain Res; 2018 Feb 15; 338():134-142. PubMed ID: 29080675
    [Abstract] [Full Text] [Related]

  • 14. Effects of acute and chronic stressors and CRF in rat and mouse tests for depression.
    Dunn AJ, Swiergiel AH.
    Ann N Y Acad Sci; 2008 Dec 15; 1148():118-26. PubMed ID: 19120099
    [Abstract] [Full Text] [Related]

  • 15. Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming.
    Price ML, Kirby LG, Valentino RJ, Lucki I.
    Psychopharmacology (Berl); 2002 Aug 15; 162(4):406-14. PubMed ID: 12172694
    [Abstract] [Full Text] [Related]

  • 16. Effects of chronic and acute stressors and CRF on depression-like behavior in mice.
    Swiergiel AH, Leskov IL, Dunn AJ.
    Behav Brain Res; 2008 Jan 10; 186(1):32-40. PubMed ID: 17716752
    [Abstract] [Full Text] [Related]

  • 17. Effects of chronic footshock, restraint and corticotropin-releasing factor on freezing, ultrasonic vocalization and forced swim behavior in rats.
    Swiergiel AH, Zhou Y, Dunn AJ.
    Behav Brain Res; 2007 Nov 02; 183(2):178-87. PubMed ID: 17645963
    [Abstract] [Full Text] [Related]

  • 18. Rats with persistently low or high exploratory activity: behaviour in tests of anxiety and depression, and extracellular levels of dopamine.
    Mällo T, Alttoa A, Kõiv K, Tõnissaar M, Eller M, Harro J.
    Behav Brain Res; 2007 Feb 27; 177(2):269-81. PubMed ID: 17141886
    [Abstract] [Full Text] [Related]

  • 19. Behavioral changes after maternal separation are reversed by chronic constant light treatment.
    Dimatelis JJ, Stein DJ, Russell VA.
    Brain Res; 2012 Oct 22; 1480():61-71. PubMed ID: 22975437
    [Abstract] [Full Text] [Related]

  • 20. PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors.
    Scheggi S, Melis M, De Felice M, Aroni S, Muntoni AL, Pelliccia T, Gambarana C, De Montis MG, Pistis M.
    Neuropharmacology; 2016 Nov 22; 110(Pt A):251-259. PubMed ID: 27457507
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.